A cautious appraisal. However, there is a possibility that there may be a very surprising rapid growth in sales. Nutraceutical or not, big sales will bring in a lot of money, and if the sales curve is rising strongly expectations about the eventual value of the company will rise correspondingly. The stock will follow those expectations, not the historical numbers.
Comet- I have to disagree with you on your assessment of hit pieces like Feuerstein's. Yes, I agree that anyone with half a brain can see through the articles for what they really are. But you don;t have to believe what is in the articles in order to believe that the articles will bring the price of the stock down. Hence, smart people and stupid people alike will bail on a stock if they perceive that the article is going to have a negative impact. I believe that has happened with the Feuerstein articles.
Market Data 
Markets 
AI
